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Objectives: This study aimed to identify the prevalence of OSA among CAD patients.
Subjects and methods: This was a cross-sectional (descriptive) study conducted at King Abdul-Aziz University
Hospital in Jeddah, Saudi Arabia from April 2012 to December 2013. All consecutive patients referred to the cardiac
catheterization lab for coronary angiography who exhibited evidence of CAD were included in this study. This
study was conducted in two stages. During the first stage, each participant was interviewed individually. The
administered interview collected data pertaining to demographics, comorbidities, and the STOP-BANG question-
naire score. The second stage of this study consisted of a diagnostic overnight polysomnography (PSG) of 50% of
the subjects at high risk for OSA according to the STOP-BANG questionnaire.
Results: Among the patients with CAD (N = 156), 128 (82%) were categorized as high risk for developing OSA.
PSG was conducted on 48 patients. The estimated prevalence of OSA in the study sample was 56.4%.
Approximately 61% of the documented sleep apnea patients suffered from moderate to severe OSA.
Conclusion: This local study concurs with reports in the literature indicating that OSA is very common among
CAD patients.
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Abbreviations
AASM American Academy of Sleep Medicine
ACS Acute Coronary Syndrome
AHI Apnea-Hypopnea Index
BMI Body Mass Index
CAD Coronary Artery Disease
IHD Ischemic Heart Disease
MI Myocardial Infarction
OSA Obstructive Sleep Apnea
PSG Polysomnography
SPSS Statistical Package for Social Sciences
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Patients with obstructive sleep apnea (OSA)experience repetitive episodes of apnea or
reduced airflow due to upper airway obstruction
during sleep. OSA appears to be related to several
cardiovascular diseases, even after adjustment for
confounding variables. These diseases include
systemic hypertension [1]; pulmonary hyperten-
sion, particularly in cases of comorbid daytime
hypoxemia [2–6]; coronary artery disease (CAD)
[7–9]; heart failure [9]; and nocturnal cardiac
arrhythmia [10–12].
Furthermore, there is increasing evidence that
severe OSA is associated with increased morbidity
and mortality related to cardiovascular disease. In
an observational study, patients with untreated
severe OSA experienced a higher incidence
of fatal and non-fatal cardiovascular events
than healthy participants, patients with mild-
moderate OSA, and even patients with severe
but treated OSA [13]. In a prospective longitudinal
epidemiological cohort study, Gottlieb et al. fol-
lowed 1927 men and 2495 women aged 40 years
or more who were free of coronary heart disease
and heart failure at the time of recruitment [9].
All participants underwent baseline polysomnog-
raphy (PSG) and were followed up for a median of
8.7 years. After adjustment for multiple risk fac-
tors, OSA was found to be a significant predictor
of incident CAD in men younger than or equal
to 70 years of age, but not in older men or in
women of any age. Accordingly, the authors con-
cluded that the association between OSA and the
incidence of coronary heart disease in this sample
was ambiguous [9].
Data from Saudi Arabia regarding OSA in stable
CAD patients are scarce. Hence, the aim of our
study was to identify its prevalence among CAD
patients (confirmed by coronary angiography)
attending a university hospital.Subjects and methods
This was a cross-sectional (descriptive) study
conducted at King Abdulaziz University Hospital
in Jeddah, Saudi Arabia, from April 2012 to
December 2013. Approval was obtained from the
hospital research ethics committee prior to con-
ducting the study. Each participant was required
to sign a consent form.
All consecutive patients referred to the cardiac
catheterization lab for elective coronary angiogra-
phy were eligible for this study. Only those withdemonstrated CAD based on coronary angiogra-
phy were recruited. Patients who refused or were
unable to participate were excluded. This study
was conducted in two stages. During the first
stage, trained physicians interviewed each partic-
ipant individually. The administered question-
naire collected data pertaining to patient
demographics, comorbidities, the STOP-BANG
questionnaire score, and coronary angiographic
findings (positive or negative for CAD). The sec-
ond stage of the study consisted of a diagnostic
overnight PSG. Due to limitation of budget, 50%
of the subjects – categorized into the high-risk
OSA group according to the STOP-BANG ques-
tionnaire – were randomly selected for PSG to
confirm OSA. A systematic random sampling
technique was followed by choosing odd numbers
on the sample list.Instruments
The STOP-BANG questionnaire [14] screens for
symptoms of OSA and has been validated for
individuals with a mean age of 57 ± 16 years. It
was originally intended for use in a preoperative
setting because untreated OSA is associated with
increased post-operative complications and
longer hospital stays [15]. This questionnaire con-
sists of four yes/no and fill-in-the-blank questions
represented by the mnemonic ‘STOP BANG’ as
follows: S (Do you Snore loudly?), T (Do you often
feel Tired, fatigued, or sleepy during the day-
time?), O (Has anyone Observed you to stop
breathing during sleep?), and P (Do you have or
are you being treated for high blood Pressure?).
To improve the accuracy of the scale, B (body
mass index or BMI), A (age), N (neck circumfer-
ence), and G (gender) are recorded. The STOP-
BANG questionnaire is scored as follows: for the
first four yes/no questions, each positive response
is assigned one point. An additional point is
added for each of the following conditions: a
Figure 1. The outline of the study groups and stages.
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more, a neck circumference of more than 40 cm,
and male gender. A total score of three or more
places the individual at a high risk for OSA [15].
PSG: This procedure was performed either at
the patient’s home using type 2 devices
(SOMNOtouch, SOMNOmedics; and Embletta
X100, Natus) or the sleep laboratory using type 1
devices (SOMNOscreen EEG 32, SOMNOm edics;
SomnoStar z4 sleep system). For tests performed
at home, 10 channels and surface leads were used
to continuously monitor the following physiologi-
cal parameters during sleep: nasal pressure, nasal
and oral airflow, respiratory effort (thoracic and
abdominal expansion), pulse rate, oxygen satura-
tion, and body position. Type 2 devices were also
used to perform electroencephalography and elec-
trooculography. The in-center devices were
equipped with 22 channels and leg sensors and
were used to continuously monitor nasal pressure,
nasal and oral airflow (thermocouple), snoring,
respiratory effort (thoracic and abdominal expan-
sion), oxygen saturation, pulse rate, and to per-
form electroencephalography, electrooculograp
hy, electromyography, and electrocardiography.
The PSG data were scored manually according
to the American Academy of Sleep Medicine
(AASM) 2012 scoring manual [16]. Apnea was
defined as the absence of airflow for at least 10 s,
and hypopnea was defined as a discernible reduc-
tion in airflow associated with a reduction in oxy-
gen saturation by at least 3% from the baseline
and/or subsequent arousal. The apnea-hypopnea
index (AHI) was defined as the average number
of apnea and hypopnea events per hour of sleep.
OSA was defined as an AHI score of P5accompanied by symptoms or signs of disturbed
sleep [17].Statistical analysis
The data were analyzed using Statistical
Package for Social Sciences (SPSS) software, ver-
sion 18. The Chi-square test was utilized to test
for the association and/or difference between the
categorical variables. Yates’ correction was
applied when appropriate. Student’s t-test was
applied to compare the means of the continuous
variables (age, weight and BMI) between the two
groups. Spearman’s correlation coefficient was
applied to test for the linear association between
AHI and age, weight, and BMI. A p value of less
than 0.05 was considered to be statistically signif-
icant. A scatterplot was generated to display the
relationship between BMI and AHI.Results
A total of 156 patients (84% males) with demon-
strated CAD based on coronary angiography were
recruited for this study. Table 1 shows the demo-
graphic data and comorbidities of the study popu-
lation. The outline of the study stages and groups
is summarized in Fig. 1.
Based on the STOP-BANG questionnaire,
patients with CAD (n = 156) were classified into
the high-risk or low-risk OSA group, as shown
in Fig. 2. The characteristics of both groups are
summarized in Table 2.
Those at high risk for developing OSA (128
patients) were eligible to participate in the second
phase of this study: a PSG test to confirm OSA
Table 1. Demographic data and characteristics of the study
population (N = 156).
N (%)
Gender
Female 25 (16)
Male 131 (84)
Smoking status
Current smoker 55 (35.3)
Former smoker 27 (17.3)
Non-smoker 74 (47.4)
Medical disease
DM 94 (60.3)
HTN 96 (61.5)
GERD 47 (30.1)
COPD 16 (10.3)
Stroke 8 (5.1)
DM: diabetes mellitus; GERD: gastro-esophageal reflux disease.
COPD: chronic obstructive pulmonary disease; HTN: hypertension.
Table 2. Comparison of high and low risk groups for
Obstructive Sleep Apnea.
High risk
N = 128
Low risk
N = 28
P-value
Mean (SD) Mean (SD)
Age (years) 57.41 (10.47) 49.54 (10.58) <0.001⁄⁄
BMI (kg/m2) 30.8 (8.09) 25.3 (5.7) <0.001⁄⁄
N (%) N (%) P-value
Gender 0.29
Female 22 (17.2%) 3 (10.7%)
Male 106 (82.8%) 25 (89.3%)
DM 84 (65.6%) 10 (35.7%) 0.004⁄⁄
HYPT 87 (68%) 9 (32.1%) 0.001⁄⁄
Stroke 7 (5.5%) 1 (3.6%) 0.56
GERD 40 (31.2%) 7 (25%) 0.34
COPD 14 (10.9%) 2 (7.1%) 0.43
Current smoker 40 (31.2%) 15 (53.6%) 0.072
Former smoker 25 (19.5%) 2 (7.1%) 0.072
BMI: body mass index; DM: diabetes mellitus; HTN: hypertension;
GERD: gastro-esophageal reflux disease; COPD: chronic obstructive
pulmonary disease.
** P value <0.05 is considered statistically significant.
Table 3. Characteristics of participants at high risk of
Obstructive Sleep Apnea who did polysomnography compared
to those who did not.
PSG group
N 48
No PSG group
N 80
P-value
Mean (SD) Mean (SD)
Age (Years) 57.9 (9.7) 57.1 (10.9) 0.387
BMI (kg/m2) 30.7 (9.0) 30.9 (7.6) 0.189
N (%) N (%) P-value
Gender
Female 8 (16.6%) 14 (17.5%) 0.904
Male 40 (83.4%) 66 (82.5%)
Smoking status
Current smoker 16 (33.3%) 24 (30%) 0.337
Former smoker 12 (25%) 13 (16.3%)
Non-smoker 20 (41.7%) 43 (53.7%)
Medical Conditions
DM 31 (64.6%) 53 (66.3%) 0.848
HTN 33 (68.8%) 54 (67.5%) 0.883
GERD 16 (33.3%) 24 (30%) 0.694
COPD 6 (12.5%) 8 (10%) 0.661
Stroke 4 (8.3%) 3 (3.8%) 0.270
DM: diabetes mellitus; GERD: gastro-esophageal reflux disease.
COPD: chronic obstructive pulmonary disease; HTN: hypertension.
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Figure 2. Classification of Coronary Artery Disease patients based on
Obstructive Sleep Apnea risk using the STOP-BANG questionnaire
(n = 156).
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the high-risk group. Unfortunately, only 48
patients (37.5%) agreed to undergo this procedure.
Nevertheless, the high-risk group of OSA patients
who had undergone PSG compared to those who
had not were similar based on demographic data,
smoking status, and medical conditions (Table 3).
Among the high-risk patients with CAD, 68.8%
suffered from OSA. Based on the assumption that
all of the low-risk patients were free of significant
sleep apnea, the prevalence of OSA in our study
population of CAD patients was estimated to be
56.4%. Two thirds of these confirmed sleep apnea
patients were of moderate and severe degree
based on AHI (Fig. 3).Discussion
In this study, we demonstrated that the preva-
lence of OSA in patients suffering from CAD is
significantly higher than reported in the general
population [18,19]. According to the STOP-
BANG questionnaire, 82% of our CAD patients
were considered to be at significantly high risk
for developing OSA compared to only 33–39% of
individuals in the general Saudi population
[18,19]. However, based on PSG, the estimated
prevalence of OSA among the CAD patients was
56.4%. These results suggest that these two condi-
tions are closely correlated in Saudi Arabia, which
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Figure 3. Pie chart displaying the severity of Obstructive Sleep Apnea according to Apnea Hypopnea Index.
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ducted elsewhere.
The higher prevalence of OSA in CAD patients
compared with the general population has been
demonstrated previously by many international
studies [20–31]. The prevalence of OSA among
patients with CAD has been reported to be as high
as 69% compared to 5–15% among the general
population, emphasizing the association between
these two conditions [31,32,33]. Mooe et al. [20]
reported the presence of OSA (AHI > 10) in 37%
of 142 patients with stable angina pectoris and
angiographically confirmed CAD. Similarly,
Peker et al. [21] reported that the prevalence of
OSA was 30% among admitted patients with acute
CAD. Furthermore, in a relatively recent prospec-
tive cohort study, PSG was performed on 89 acute
coronary syndrome (ACS) patients who under-
went percutaneous coronary intervention (53 with
acute myocardial infarction (MI) and 36 with
unstable angina) [27]. In this study, OSA (defined
as an AHIP 10) was detected in 51 patients (57%),
similar to our findings [27]. In another study, OSA
was reported in 63.7% (422 out of 662) of re-
vascularized CAD patients [28]. Among ischemic
cardiomyopathy patients, on the other hand,
Oldenburg et al stated that 36% were documented
to suffer from OSA [29]. More recently, Tan et al.
reported that 32 (34.4%) of 93 CAD patients exhib-
ited moderate to severe OSA [30]. This wide vari-
ation in the prevalence of OSA among CAD
patients can be partially explained by differences
in the methodologies and study populations
assessed in these studies. It is believed that stud-
ies reporting relatively low prevalence rates may
underestimate the actual frequency of OSA
among CAD patients. Recently, Konecny et al.
[31] emphasized the under-recognition of OSA
among patients admitted with acute CAD. The
primary finding of this study was the low rate(12%) of documented or suspected OSA among
789 patients hospitalized for acute MI based on
chart reviews. These findings conflicted with the
high prevalence of OSA (69%) among 74 MI
patients who underwent prospective evaluations
using PSG. Based on this study, it is tempting to
postulate that the association between OSA and
CAD has been under-reported and under-
diagnosed [31].
Conversely, CAD has also been frequently
found in OSA patients. Pecker et al. conducted a
long-term clinic-based observational study. Over
seven years, the investigators reported CAD in
16.2% of patients with OSA compared with 5.4%
of snorers without OSA [34]. Furthermore, several
subsequent studies have demonstrated that
patients with untreated severe OSA exhibit an
increased incidence of fatal and nonfatal cardio-
vascular events (including MI and ACS) compared
with those without sleep apnea or even with those
with untreated mild to moderate OSA [7–9,13,35].
However, such an association suggests but does
not demonstrate a causal relationship.
Nevertheless, data from Saudi Arabia on the
association between OSA and CAD are scarce.
BaHammam et al. examined the prevalence of
OSA among patients presenting with acute coro-
nary artery syndrome [36]. They reported that
56% of the study population (50 patients) exhib-
ited OSA based on PSG according to an
AHI > 10, and their conditions persisted even at
six months after the initial acute event [36].
Although the total number of patients who
underwent PSG in our study was relatively small,
approximately 40% of those with sleep apnea were
classified as severe based on the AHI criteria
(Fig. 3). These findings may be consistent with
the aforementioned association between
untreated severe OSA and the development of
adverse cardiovascular events. In addition, the
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ated with a worsening of sleep-disordered breath-
ing. This hypothesis was demonstrated in a
prospective cohort study of 2721 individuals with-
out CAD who were followed up for a mean of five
years. PSG was performed at baseline and after
five years [37]. Those who had experienced MI
exhibited an increase in the AHI of a mean of
6.37 respiratory events per hour of sleep com-
pared to an increase of only 2.71 events among
those who had not experienced MI [37].
The most important risk factors for OSA include
advanced age, male gender, and obesity [11,32]. In
our study, age and obesity prevalence were signif-
icantly higher in the high-risk OSA group than in
the low-risk OSA group (Table 2). However, the
small number of females in our study may account
for the lack of a significant gender difference
between these two groups. In addition, although
smoking may increase the risk or worsen the
symptoms of OSA [38], this result was not con-
firmed in our study, which was likely due to the
relatively small sample size.
OSA has been closely associated with adverse
clinical outcomes, including hypertension [1] and
diabetes mellitus [39], which were clearly
observed in our study, as both hypertension and
diabetes were observed more frequently in the
high-risk OSA group than in the low-risk OSA
group. Furthermore, OSA has been associated
with an increased risk of ischemic stroke [40].
However, the small number of patients who had
experienced stroke in our sample may explain
the lack of a significant difference between these
two groups (Table 2).
This link between CAD and OSA is not surpris-
ing because both share common risk factors, such
as obesity, male gender, increased age, and smok-
ing status [42]. The worldwide obesity pandemic,
particularly in Saudi Arabia, has actually increased
the risk of both conditions [43]. Nevertheless, it has
been postulated that the correlation between CAD
and OSA is independent of these risk factors.
Indeed, Peker et al. studied 182 men with suspected
OSA who were free of other risk factors for
Ischemic Heart Disease (IHD), such as hyperten-
sion and diabetes mellitus [43]. These authors
found that 36.7% of individuals with OSA
developed CAD compared to 6.6% of subjects
without OSA (p < 0.001), suggesting that the
association between these two conditions is inde-
pendent of other risk factors, including obesity [43].
Our study contained some limitations, primarily
involving the sample size and the performance of
a single center rather than a multi-center study.Another limitation of our study was that not all
patients underwent PSG to confirm OSA.
However, the sample underwent a confirmatory
test was not different in terms of demographic
parameters, smoking status, and medical condi-
tions from the whole high risk group (Table 3).
In addition, unlike other previous studies, which
utilized the Berlin questionnaire, we used the
STOP-BANG questionnaire to determine the risk
for OSA. The systematic review performed by
Abrishami et al. did not reach a definitive conclu-
sion regarding the most accurate questionnaire to
use for OSA screening. However, they recom-
mended the STOP-BANG questionnaire due to
its high-quality methodology and reasonably
accurate results [44].
In conclusion, our study demonstrated that
many patients with CAD are either at risk for
developing OSA or already suffer from OSA.
This correlation may have serious consequences
since OSA exacerbates CAD. Therefore, clinicians
should be aware of the coexistence of these two
conditions in Saudi Arabian patients and should
endeavor to address both conditions simultane-
ously. Although CAD alone is not an indication
for a diagnostic evaluation of OSA, the presence
of this condition should prompt the clinician to
consider whether there are other signs or symp-
toms of OSA that indicate a diagnostic evaluation.References
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